Draft:Thomas Douglas Bradley

Thomas Douglas Bradley is a distinguished Canadian physician and researcher specializing in sleep medicine and respiratory disorders. He currently serves as the professor of medicine and is the former department division director, respirology, at the University of Toronto. Additionally, he holds positions at the Cardiopulmonary Sleep Disorders and Research Centre at the Toronto General Hospital/University Health Network, and the Sleep Research Laboratory at the Toronto Rehabilitation Institute. Bradley is recognized for his contributions to understanding the relationship between sleep disorders, particularly sleep apnea, and cardiovascular diseases.

He has published over 280 research papers and has over 25k citations with an h-index of 80.

Education and career
Bradley completed his medical degree at the University of Alberta in Edmonton in 1978. He then pursued specialty training in internal medicine and respirology at the University of Toronto, completing his training in 1982.

Following his clinical training, Bradley dedicated three years to research in sleep apnea and respiratory muscle physiology, conducted at the University of Toronto and McGill University.

Since 1985, Bradley has been on staff at the Toronto General Hospital and the University of Toronto, where he has continued his clinical practice and research endeavors.

Research and contributions
Bradley's research primarily focuses on the relationship between sleep apnea and cardiovascular diseases, particularly in patients with heart failure. He has received numerous grants from the Canadian Institutes of Health Research (CIHR), the Ontario Centres of Excellence, and the Heart and Stroke Foundation of Ontario to support his research efforts.

His work helped in advancing the understanding of sleep disorders and their impact on cardiovascular health. More recently, he was the lead author on a multinational research trial demonstrating that treating sleep apnea in patients with heart failure with reduced ejection fraction improved sleep quality, symptoms of heart failure and quality of life.

BresoDX1 and medical innovation
Bradley is a co-founder of BresoTec Inc., a company that developed BresoDX1, an at-home sleep apnea diagnostic testing device. BresoDX1 recently received clearance from the United States Food and Drug Administration (FDA), and Health Canada.